A Agilent Technologies

  • Official Name: AGILENT TECHNOLOGIES, INC.
  • Headquarters: 5301 Stevens Creek Blvd, SANTA CLARA, CA, 95051 US
  • CEO: Padraig McDonnell
  • Website: agilent.com

Match Results

Date League Week Opponent Result Score
2025-07-15 1R Lost by 2.085 (4.683) - (2.598)
2025-07-17 1 Lost by 5.828 (3.827) - 2.001
2025-07-24 2 Lost by 6.867 3.546 - 10.413
2025-07-31 3 Won by 0.932 (4.615) - (5.547)
2025-08-07 4 Won by 5.066 (0.854) - (5.920)
2025-08-07 1R Won by 2.747 0.931 - (1.816)
2025-08-14 5 Lost by 15.593 4.554 - 20.147
2025-08-21 6 Lost by 1.073 (4.380) - (3.307)
2025-08-21 2R Lost by 1.878 (1.784) - 0.094
2025-08-28 7 Lost by 0.047 7.054 - 7.101
2025-09-04 8 Won by 4.513 2.449 - (2.064)
2025-09-11 9 Lost by 4.205 (1.319) - 2.886
2025-09-18 10 Won by 0.777 0.654 - (0.123)
2025-09-25 11 Lost by 0.958 (4.265) - (3.307)
2025-10-02 12 Won by 14.828 12.423 - (2.405)
2025-10-09 13 Lost by 2.395 1.110 - 3.505
2025-10-16 14 Lost by 7.957 0.717 - 8.674
2025-10-23 15 Lost by 2.487 4.503 - 6.990

Latest News

1 Surging Healthcare Stock Worth Your Attention and 2 We Turn Down
Yahoo - 2026-10-16

1 Surging Healthcare Stock Worth Your Attention and 2 We Turn Down 🔗

The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, ...

Immuno-Oncology Diagnostics Market to Reach $11.1B by 2030 as Checkpoint Inhibitor and Cell Therapy Pipelines Drive Demand for Companion Tests
Yahoo - 2026-10-16

Immuno-Oncology Diagnostics Market to Reach $11.1B by 2030 as Checkpoint Inhibitor and Cell Therapy Pipelines Drive Demand for Companion Tests 🔗

Report Tracks Roche Diagnostics, Thermo Fisher, Illumina, Agilent and Guardant Health Among 132 Companies, With Forecasts by Assay Type, Technology, C...

Agilent acquires Proscia in deal worth up to $270m
Yahoo - 2026-10-14

Agilent acquires Proscia in deal worth up to $270m 🔗

The transaction, which is expected to close in Agilent’s fiscal year 2027, follows its $950m acquisition of Biocare Medical in March 2026.

Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist
Benzinga - 2026-10-14

Why Agilent Is Spending up to $270 Million on an AI Pathology Specialist 🔗

Agilent (A) to acquire Proscia for up to $270M to expand AI-powered digital pathology & diagnostic capabilities. Stock edges higher.

Global Metabolomics Market Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on 17.3% CAGR as Thermo Fisher, Bruker, Agilent, and Metabolon Accelerate AI Diagnostics
Yahoo - 2026-10-14

Global Metabolomics Market Report 2026: Size, Trends, and Forecast to 2030 | Capitalize on 17.3% CAGR as Thermo Fisher, Bruker, Agilent, and Metabolon Accelerate AI Diagnostics 🔗

Players: Metabolon, Bruker, Agilent, Thermo Fisher and Waters. Profiles cover products, services, market share, segments, trends, opportunities and re...

Agilent to buy Proscia for $240M
Yahoo - 2026-10-14

Agilent to buy Proscia for $240M 🔗

The digital pathology firm “fits in very well” with Agilent and moves the company into a sector targeted by Roche, analysts said.

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence
Yahoo - 2026-10-13

Agilent to Acquire Proscia, Advancing AI-Enabled Digital Pathology and Scientific Intelligence 🔗

SANTA CLARA, Calif. & PHILADELPHIA, October 13, 2026--Agilent Technologies Inc. (NYSE: A) today announced it has entered into a definitive agreeme...

Benzinga - 2026-10-13

TD Cowen Maintains Buy on Agilent Technologies, Raises Price Target to $196 🔗

TD Cowen analyst Dan Brennan maintains Agilent Technologies (NYSE:A) with a Buy and raises the price target from $180 to $196.

Benzinga - 2026-10-13

Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $190 🔗

Morgan Stanley analyst Kallum Titchmarsh maintains Agilent Technologies (NYSE:A) with a Overweight and raises the price target from $175 to $190.

Global Chromosomal Microarray Reflex Testing Market Report 2026-2030 | Capitalize on 9.1% CAGR as Thermo Fisher, LabCorp, Illumina, Agilent, and Natera Scale Precision Genomics
Yahoo - 2026-10-13

Global Chromosomal Microarray Reflex Testing Market Report 2026-2030 | Capitalize on 9.1% CAGR as Thermo Fisher, LabCorp, Illumina, Agilent, and Natera Scale Precision Genomics 🔗

Dublin, Oct. 13, 2026 (GLOBE NEWSWIRE) -- "Chromosomal Microarray Reflex Testing Global Market Report 2026" has been added to ResearchAndMar...

Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year?
Yahoo - 2026-10-12

Is Agilent Technologies (A) Outperforming Other Medical Stocks This Year? 🔗

Here is how Agilent Technologies (A) and Concentra Group (CON) have performed compared to their sector so far this year.

Show more